Regulation & Compliance

After its stock plummeted post-IPO, Chinese health-tech firm POMDOCTOR faces a Nasdaq delisting threat, forcing a reckoning with its massive losses.

A new FinTech giant is born. Teciem spins out of Finastra with Apax backing, a $2B valuation, and a plan to innovate for the world's top banks.

A life-changing treatment for a rare kidney disease is now easily accessible in France, ending a long wait for patients and bolstering a French pharma firm.

Early clinical results for MP0712, a novel Radio-DARPin, suggest a breakthrough for targeting aggressive cancers like SCLC while sparing healthy tissue.

After 18 negotiating sessions, 1,200 Teamsters at Rush University Medical Center won a new contract with major wage and benefit gains, setting a new bar.

A lawsuit seeks to block drastic cuts to Florida's ADAP program, which could strip thousands of life-saving HIV medication and insurance by March 1.

The Corrections Center of Northwest Ohio lauds a smooth healthcare transition, but its new partner, Armor Health, brings a history of lawsuits and financial turmoil.

360 Delaware customers get a new water provider as Tidewater Utilities' acquisition highlights a trend of utility consolidation and promises service upgrades.

Tevogen Bio's stock surged on news of a potential special dividend, but a closer look reveals a risky promise from a pre-revenue firm facing major hurdles.

The CFP Board disciplined nine individuals, revoking certifications for roles in a Ponzi scheme and fraud, reinforcing its role as an ethical watchdog.

Corcept Therapeutics' stock plummeted and it now faces legal probes after the FDA rejected its key drug, revealing the company was warned not to apply.

Promising Phase 2 data for a potential first-in-class neuropathic corneal pain therapy to be showcased, offering new hope for a debilitating condition.

Asante Gold boosts its war chest with a C$13.8M private placement led by its own chairman, fueling aggressive expansion at its Ghanaian gold mines.

Incyte's Zynyz gets a key EU panel's nod, offering a breakthrough for advanced anal canal cancer patients after decades of limited treatment options.

Enterprises are stuck in AI pilot mode. A new generation of startups is breaking the logjam with solutions for data, training, and compliance.

With backing from a top hospital, VolitionRx seeks reimbursement for its Nu.Q® blood test, aiming to transform lung cancer care in France and beyond.

With a $150M partnership, Nada and Medalist are betting big on Home Equity Agreements. Is this the future for homeowners seeking cash without debt?

Ad tech firm Publift achieves Google's top-tier Premier Partner status, promising enhanced revenue and strategic support for publishers in a changing ad landscape.

A key expansion order validates Actelis' hybrid network tech, helping a major energy operator modernize its critical infrastructure against new cyber risks.

An Austin-based tech company's platform, which integrates into doctors' workflows, has cut prescription costs for nearly 60,000 Ohio residents.